Pfizer buying BioRexis Pharmaceutical
Pfizer buying BioRexis Pharmaceutical
Pfizer buying BioRexis Pharmaceutical
Drug developer Pfizer Inc. said Thursday it is buying privately held BioRexis Pharmaceutical Corp. for an undisclosed amount.
BioRexis is developing several treatments for diabetes. The technology being used to develop those treatments uses protein engineering and could have the potential to improve drug tolerability and reduce dosing frequency, Pfizer said.
Boutique executive search services with best in class global network, contacts and market mastery.
Deeply connected and engaged personal service approach, long-term investment in client community and 25 year history of strong relations with both Multi-National leaders and Private Equity partners.